Showing 2 posts of 2 posts found.
You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …
Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation